Uncategorized

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test

BD, a leading global medical technology company, announced U.S. Food and Drug Administration 510 clearance for the BD Respiratory Viral Panel for BD MAX™ System, a single molecular diagnostic combination test that identifies and distinguishes SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus in approximately two hours.

BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test Read More »

Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service

Metrion Biosciences Limited announced it has received notification from the UK’s Medicines and Healthcare products Regulatory Agency that the Company is now a member of the UK GLP Compliance Monitoring Programme, and is therefore able to offer GLP compliant hERG ion channel screening services to the global life sciences community.

Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service Read More »

Scroll to Top